Recent Advances in Cancer treatments
On behalf of the Journal of Cancer Clinical Trials, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been Four long years we have started the Journal, now we are celebrating the 4th Anniversary and we are privileged to welcome Analytical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Cancer Clinical Trials.
The Journal of Cancer Clinical Trials aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Chromatography. The open access journal is published by OMICS International who hosts around 350 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal is successfully running in the 10th Volume which covers a wide variety of specialties including Cancer Surgery, Ovarian cancer, hepatitis infection, reaching out to analytical scientists worldwide. The Journal emphasizes high-level research and education. Original research articles, reviews, short communications, and letters to the editors in the fields of clinical trials are welcome. Every effort is made to have a speedy and critical peer-review process.
Realizing the importance of this field, OMICS Group has organized a prestigious conference on Cancer Diagnostics Conference & Expo which was held from june 13-15, 2016 Rome, Italy under the theme ‘Enhancing innovations in Cancer Diagnosis and treatment.
The conference includes around 50 Abstracts and 30 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.
Eminent speakers lined up to share valuable include Diana Anderson, Tibor Tot and many more.
Assistant Editorial Manager
Journal Cancer clinical Trials